Genmab A/S
Genmab A/S (GNMSF) Stock Overview
Explore Genmab A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
16.9B
P/E Ratio
27.00
EPS (TTM)
$15.36
ROE
0.14%
GNMSF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Genmab A/S (GNMSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 30.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $220.80.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.00 and a market capitalization of 16.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.